Futura Medical Share Discussion Threads

[lbo] 12/3/2023 21:25

So where did Futura get the ‘IDEA’ to market the placebo MED3000 gel after MED2005 gel (Dermasys & GTN) failed its Phase 3 trial?

Look no further then Futuras TPR100 (dermasys & Diclofenac). Yes the pain product gel in manufacturing scale up limbo with Thornton & Ross since 2017.

One of Futuras transdermal delivery competitors according to Edison (see link) was working on IDEA-033 (transfersome gel & Ketoprofen). J&J had the the rights to IDEA-033 before they walked away as it too like Med2005 failed its phase 3 drug trail.

Which then left Pro Bono Bio (PBB) with just the sham placebo Flexiseq (Transfersome gel on its own often referred to as TDT064 in the scientific literature). You couldn’t make it up if you tried.

And coincidentally Glaxo also walked away from Futuras TPR100 as well as the MED product. They learned all they needed to know about Dermasys is just a placebo and walked away.

[petroc] 12/3/2023 21:18

The multi-ID stock basher (aka LiamBooth, Leveraged, Citygirl, sbgae, LBO8 et al) is making contradictory claims to the results found in two clinical tests and a home use trial. The vast majority of users confirmed that Eroxon works. LiarBO can't show a single piece of evidence that shows otherwise, which is why he has to use spurious and unrelated links in an attempt to tar Eroxon.

LiarBO recycles the same posts over and over again, and therefore gets the same answers each time. 'Insanity is doing the same thing over and over and expecting different results.'

[petroc] 12/3/2023 21:17

'The Petroc multi-ID bot must be broken and seems to be stuck repeating the same post!'

Oh, the irony!

[petroc] 12/3/2023 21:01

"Rusnano invests hundreds of million dollars in placebo 'nano-gel'. Clinical tests of Flexiseq ointment have not proved its effectiveness. The drug was to be distributed by a friend of a Rusnano senior executive"
Another day another scam in Russia...
en.crimerussia.com/corruption/rus…

hxxps://staging.threadreaderapp.com/thread/980229644547915776.html

[lbo] 12/3/2023 20:46

Yes like the irony of you saying Flexiseq is a ‘Russian scam’. Which by your definition means Eroxon is a English AIM market scam! LOL





Flexiseq was a certified Class IIb medical device. We understood that the device certification was granted by a body within the European Member States that had been designated to carry out conformity assessments under the Medical Device Directive.


I wonder how much money and ‘work hard to build Eroxon™ into a long term, profitable and trusted brand’ will be required when it still has no enforceable patent!?



The royalty and the royalty advance may be reduced by such amount (if any) as is agreed or determined by an expert to be fair and reasonable if: (i) any patent application does not proceed to grant or any patent rights are determined to be unenforceable or are revoked or lapse; or (ii) an event occurs which in LRC reasonable opinion adversely affects the commercial viability of the licence agreement or the margins on sales of the Product; or (iii) a competing product is offered




‘Futura does not have the marketing or regulatory resources to support the day-to-day requirements in a growing compliance-driven medical device market’

˜the immediate potential for substantial royalties is low in the absence of a large global brand 'carrier' to take the product forward’

[petroc] 12/3/2023 19:29

The multi-ID stock basher (aka LiamBooth, Leveraged, Citygirl, sbgae, LBO8 et al) is making contradictory claims to the results found in two clinical tests and a home use trial. The vast majority of users confirmed that Eroxon works. LiarBO can't show a single piece of evidence that shows otherwise, which is why he has to use spurious and unrelated links in an attempt to tar Eroxon.

LiarBO recycles the same posts over and over again, and therefore gets the same answers each time. 'Insanity is doing the same thing over and over and expecting different results.'

[petroc] 12/3/2023 19:28

'The Petroc multi-ID bot must be broken and seems to be stuck repeating the same post!'

Oh, the irony!

[lbo] 12/3/2023 19:15

And the rampers are aware of all this from the failed TPR100 product stuck in limbo! Its even already been openlyadmitted the Dermasy vehicle and Voltaren vehicle gave similar results! LOLhttps://indigo.bluematrix.com/indigo/Viewer.action?info=U7Z%2F%2BSxWYbPQB8QtqH%2Bh5KgushbvU5dK'TPR100 gave similar results to the gold standard, Voltarol 2% gel'https://www.gskhealthpartner.com/content/dam/cf-consumer-healthcare/health-professionals/en_IN/pdf/article-1.pdfThe cooling effect of a topically applied product can be evaluated using a validated handheld thermal imaging system. When the gel matrix is destroyed after application to the skin, the bound water and alcohol evaporates and a measurable cooling-effect results. Consumer satisfaction with a topical product is based on subjective criteria such as how the product feels and how it is perceived on the skin. Therefore, appropriate questionnaires are of major importance for cosmetic products to assess the subjective perception not only of soothing and cooling effects but also of moisturizing properties and fragrance.https://www.edisoninvestmentresearch.com/?ACT=18&ID=10479A key element of Futura Medicals strategy is to reduce development risk through using well characterised existing agents that are reformulated with its proprietary DermaSys technology to create new products. This means intellectual property protection is limited to use patents for the individual products and umbrella patents for the technology. There is a risk that some claims will either be challenged in future (eg on the grounds of non-obviousness or existence of prior art) and/or that another technology may be employed to achieve a similar effect

[petroc] 12/3/2023 17:50

The multi-ID stock basher (aka LiamBooth, Leveraged, Citygirl, sbgae, LBO8 et al) is making contradictory claims to the results found in two clinical tests and a home use trial. The vast majority of users confirmed that Eroxon works. LiarBO can't show a single piece of evidence that shows otherwise, which is why he has to use spurious and unrelated links in an attempt to tar Eroxon.

LiarBO recycles the same posts over and over again, and therefore gets the same answers each time. “Insanity is doing the same thing over and over and expecting different results.”

[petroc] 12/3/2023 17:47

'The Petroc multi-ID bot must be broken and seems to be stuck repeating the same post!'

Oh, the irony!

[lbo] 12/3/2023 15:19

Even Trinity Research who are paid by Futura has contradicted the rampers and had to openly admit the hypothesised effects 'believes' to be happening by Futura are 'disputed'https://www.discovermagazine.com/health/the-erection-of-a-placebo˜There is no evidence for the evaporative mode of action from the clinical trials. To show that the evaporation is what makes MED3000 work, you'd need to compare it to a non-evaporative gel'https://www.ftc.gov/system/files/documents/public_statements/996984/p114505_otc_homeopathic_drug_enforcement_policy_statement.pdfProof is what separates an effect new to science from a swindle . . . . If a condition responds to treatment, then selling a placebo as if it had therapeutic effect directly injures the consumer. FTC v. QT, Inc.Trinity also admitted no mechanism of action has to be even shown to just get a low class medical device registered.But it does need to be shown and proven to substantiate its marketing claims of having any effect beyond a placebo or even arousal gel with the same alcohol, water, glycol and carbomer ingredients or fall foul of the FTC, ASA and the Courts.Trinity research:Presumably the effect is comparable to the cold-induced vasodilation (CIVD) that occurs with extremities such as toes and fingers. Despite being a well-known effect, the mechanisms of CIVD are still disputed, but the pathways involved could well be similar. Interestingly, the precise mechanism of action does not need to be elucidated for the regulators to be comfortable for a product to be approved as a medical deviceââ‚

[lbo] 12/3/2023 15:06

Still waiting for you to substantiate any of your false and misleading claims with non deficient evidence!?

And I am not ‘making contradictory claims to the results found in two clinical tests and a home use trials’ Quite the contrary’’

Those results from the deficient tests do not prove the gel is having any effect beyond a placebo gel!

And no ˜vast majority of users confirmed that Eroxon works’ any better then a placebo gel or even an arousal gel in any non deficient adequately controlled and blinded study.

And I don’t nor does any consumer need to ˜show a single piece of evidence that shows otherwise’.

The onus is on the advertiser or ramper making the implied claim that it works beyond a placebo gel or an arousal gel to have the evidence to substantiate that claim before it implies ‘it works’ and is˜clinically proven’ beyond a placebo or even an arousal gel under the same deficient test circumstances.

So the burden of proof to supply the evidence from an adequately placebo controlled study to substantiate ‘it works’ beyond what any placebo gel or even arousal gel would work in those same deficient trsts is on the advertiser/ramper making the claim that the product ‘it works’.

The onus is also on that same advertiser/ramper to also disclose the limitations of the evidence if they were relying on deficient studies to make a claim ‘it works’



Administrative Law Judge Upholds FTC's Complaint that POM Deceptively Advertised Its Products erectile dysfunction claims were false and unsubstantiated because the study on which the company relied did not show that POM Juice was any more effective than a placebo.



It is the advertisers responsibility to hold evidence for the claims they make, and it is stipulated in the Advertising Codes that evidence must be held by the advertiser prior to making the claim. Advertisers must submit documentary evidence to the ASA to support any claims they make; the ASA will not seek out the evidence to establish the veracity of the claim for you.

[petroc] 12/3/2023 14:15

The multi-ID stock basher (aka LiamBooth, Leveraged, Citygirl, sbgae, LBO8 et al) is making contradictory claims to the results found in two clinical tests and a home use trial. The vast majority of users confirmed that Eroxon works. LiarBO can't show a single piece of evidence that shows otherwise, which is why he has to use spurious and unrelated links in an attempt to tar Eroxon.